AMGN vs HQY · P/E 24, rev $10.05B vs P/E 73, rev $705.4M
Amgen Inc (AMGN) versus HealthEquity Inc (HQY) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
HealthEquity Inc (HQY) is a health information services company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported HQY revenue for 2026-07-31 was $705.4M. Net income was $135.1M. Revenue was up 98.9% from 2026-04-30 to 2026-07-31. HQY currently screens at market cap $8.65B and trailing P/E 73.0.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. HQY currently screens at market cap $8.65B and trailing P/E 73.0.
Not investment advice. Open the AMGN and HQY stock pages for the full models.
Not investment advice.